相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Longitudinal Change in CSF Biomarkers in Autosomal-Dominant Alzheimer's Disease
Anne M. Fagan et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
CSF biomarker variability in the Alzheimer's Association quality control program
Niklas Mattsson et al.
ALZHEIMERS & DEMENTIA (2013)
Clinical Utility and Analytical Challenges in Measurement of Cerebrospinal Fluid Amyloid-β1-42 and τ Proteins as Alzheimer Disease Biomarkers
Ju-Hee Kang et al.
CLINICAL CHEMISTRY (2013)
Cerebrospinal Fluid Levels of β-Amyloid 1-42, but Not of Tau, Are Fully Changed Already 5 to 10 Years Before the Onset of Alzheimer Dementia
Peder Buchhave et al.
ARCHIVES OF GENERAL PSYCHIATRY (2012)
Proteomic Changes in Cerebrospinal Fluid of Presymptomatic and Affected Persons Carrying Familial Alzheimer Disease Mutations
John M. Ringman et al.
ARCHIVES OF NEUROLOGY (2012)
Effect of Immunotherapy With Bapineuzumab on Cerebrospinal Fluid Biomarker Levels in Patients With Mild to Moderate Alzheimer Disease
Kaj Blennow et al.
ARCHIVES OF NEUROLOGY (2012)
Analytical aspects of molecular Alzheimer's disease biomarkers
Ulf Andreasson et al.
BIOMARKERS IN MEDICINE (2012)
Upcoming candidate cerebrospinal fluid biomarkers of Alzheimer's disease
Anne M. Fagan et al.
BIOMARKERS IN MEDICINE (2012)
Chromogranin A at the Crossroads of Health and Diseasee
T. Angelone et al.
CURRENT MEDICINAL CHEMISTRY (2012)
The role of NrCAM in neural development and disorders-Beyond a simple glue in the brain
Takeshi Sakurai
MOLECULAR AND CELLULAR NEUROSCIENCE (2012)
CSF VILIP-1 predicts rates of cognitive decline in early Alzheimer disease
R. Tarawneh et al.
NEUROLOGY (2012)
Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease
Randall J. Bateman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Stability of the Transthyretin Molecule as a Key Factor in the Interaction with A-Beta Peptide - Relevance in Alzheimer's Disease
Carlos A. Ribeiro et al.
PLOS ONE (2012)
Complement 3 and Factor H in Human Cerebrospinal Fluid in Parkinson's Disease, Alzheimer's Disease, and Multiple-System Atrophy
Yu Wang et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
Visinin-like Protein-1: Diagnostic and Prognostic Biomarker in Alzheimer Disease
Rawan Tarawneh et al.
ANNALS OF NEUROLOGY (2011)
Neuronal Production of Transthyretin in Human and Murine Alzheimer's Disease: Is It Protective?
Xinyi Li et al.
JOURNAL OF NEUROSCIENCE (2011)
Proteomics of human cerebrospinal fluid: Discovery and verification of biomarker candidates in neurodegenerative diseases using quantitative proteomics
A. C. Kroksveen et al.
JOURNAL OF PROTEOMICS (2011)
Identification and Validation of Novel Cerebrospinal Fluid Biomarkers for Staging Early Alzheimer's Disease
Richard J. Perrin et al.
PLOS ONE (2011)
Multiplexed Immunoassay Panel Identifies Novel CSF Biomarkers for Alzheimer's Disease Diagnosis and Prognosis
Rebecca Craig-Schapiro et al.
PLOS ONE (2011)
Novel CSF biomarkers for Alzheimer's disease and mild cognitive impairment
William T. Hu et al.
ACTA NEUROPATHOLOGICA (2010)
Biomarker discovery for Alzheimer's disease, frontotemporal lobar degeneration, and Parkinson's disease
William T. Hu et al.
ACTA NEUROPATHOLOGICA (2010)
Skyline: an open source document editor for creating and analyzing targeted proteomics experiments
Brendan MacLean et al.
BIOINFORMATICS (2010)
YKL-40: A Novel Prognostic Fluid Biomarker for Preclinical Alzheimer's Disease
Rebecca Craig-Schapiro et al.
BIOLOGICAL PSYCHIATRY (2010)
Combined analysis of the glia secretome and the CSF proteome: neuroinflammation and novel biomarkers
Kyoungho Suk
EXPERT REVIEW OF PROTEOMICS (2010)
In vivo CHI3L1 (YKL-40) expression in astrocytes in acute and chronic neurological diseases
Dafna Bonneh-Barkay et al.
JOURNAL OF NEUROINFLAMMATION (2010)
Neuronal Pentraxins Mediate Silent Synapse Conversion in the Developing Visual System
Selina M. Koch et al.
JOURNAL OF NEUROSCIENCE (2010)
Application of an End-to-End Biomarker Discovery Platform to Identify Target Engagement Markers in Cerebrospinal Fluid by High Resolution Differential Mass Spectrometry
Cloud P. Paweletz et al.
JOURNAL OF PROTEOME RESEARCH (2010)
Multiple sclerosis: Identification and clinical evaluation of novel CSF biomarkers
Jan Ottervald et al.
JOURNAL OF PROTEOMICS (2010)
GRANINS AS DISEASE-BIOMARKERS: TRANSLATIONAL POTENTIAL FOR PSYCHIATRIC AND NEUROLOGICAL DISORDERS
A. Bartolomucci et al.
NEUROSCIENCE (2010)
Biomarkers of Alzheimer's disease
Rebecca Craig-Schapiro et al.
NEUROBIOLOGY OF DISEASE (2009)
Longitudinal Study of CSF Biomarkers in Patients with Alzheimer's Disease
Peder Buchhave et al.
PLOS ONE (2009)
The brain injury biomarker VLP-1 is increased in the cerebrospinal fluid of Alzheimer disease patients
Jin-Moo Lee et al.
CLINICAL CHEMISTRY (2008)
Amyloid Precursor Protein Trafficking, Processing, and Function
Gopal Thinakaran et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Application of targeted quantitative proteomics analysis in human cerebrospinal fluid using a liquid chromatography matrix-assisted laser desorption/ionization time-of-flight tandem mass spectrometer (LC MALDI TOF/TOF) platform
Sheng Pan et al.
JOURNAL OF PROTEOME RESEARCH (2008)
Identification of a novel panel of cerebrospinal fluid biomarkers for Alzheimer's disease
A. H. Simonsen et al.
NEUROBIOLOGY OF AGING (2008)
Structural and quantitative comparison of cerebrospinal fluid glycoproteins in Alzheimer's disease patients and healthy individuals
Carina Sihlbom et al.
NEUROCHEMICAL RESEARCH (2008)
mGluR1/5-Dependent long-term depression requires the regulated ectodomain cleavage of neuronal pentraxin NPR by TACE
Richard W. Cho et al.
NEURON (2008)
Both plasma retinol-binding protein and haptoglobin precursor allele 1 in CSF: Candidate biomarkers for the progression of normal to mild cognitive impairment to Alzheimer's disease
Sang Min Jung et al.
NEUROSCIENCE LETTERS (2008)
Multicenter assessment of CSF-phosphorylated tau for the prediction of conversion of MCI
M. Ewers et al.
NEUROLOGY (2007)
Identification and validation of novel CSF biomarkers for early stages of Alzheimer's disease
Yan Hu et al.
PROTEOMICS CLINICAL APPLICATIONS (2007)
Plasma and CSF serpins in Alzheimer disease and dementia with Lewy bodies
H. M. Nielsen et al.
NEUROLOGY (2007)
Longitudinal changes of CSF biomarkers in memory clinic patients
F. H. Bouwman et al.
NEUROLOGY (2007)
Longitudinal stability of CSF biomarkers in Alzheimer's disease
Kaj Blennow et al.
NEUROSCIENCE LETTERS (2007)
Novel panel of cerebrospinal fluid biomarkers for the prediction of progression to Alzheimer dementia in patients with mild cognitive impairment
Anja H. Simonsen et al.
ARCHIVES OF NEUROLOGY (2007)
Cerebrospinal fluid proteomic biomarkers for Alzheimer's disease
Erin J. Finehout et al.
ANNALS OF NEUROLOGY (2007)
Cerebrospinal fluid diagnostic markers correlate with lower plasma copper and ceruloplasmin in patients with Alzheimer's disease
H. Kessler et al.
JOURNAL OF NEURAL TRANSMISSION (2006)
Synapse formation and function is modulated by the amyloid precursor protein
Christina Priller et al.
JOURNAL OF NEUROSCIENCE (2006)
Comparative proteomic analysis of intra- and interindividual variation in human cerebrospinal fluid
Y Hu et al.
MOLECULAR & CELLULAR PROTEOMICS (2005)
Albumin depletion of human plasma also removes low abundance proteins including the cytokines
J Granger et al.
PROTEOMICS (2005)
Complement protein isoforms in CSF as possible biomarkers for neurodegenerative disease
EJ Finehout et al.
DISEASE MARKERS (2005)
Quantitative proteomic analysis of age-related changes in human cerebrospinal fluid
Z Jing et al.
NEUROBIOLOGY OF AGING (2005)
Cerebrospinal fluid tau and β-amyloid -: How well do these biomarkers reflect autopsy-confirmed dementia diagnoses?
CM Clark et al.
ARCHIVES OF NEUROLOGY (2003)
A panel of cerebrospinal fluid potential biomarkers for the diagnosis of Alzheimer's disease
O Carrette et al.
PROTEOMICS (2003)
Absolute quantification of proteins and phosphoproteins from cell lysates by tandem MS
SA Gerber et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Proteome analysis of cerebrospinal fluid proteins in Alzheimer patients
P Davidsson et al.
NEUROREPORT (2002)